Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PediaBerry for Infantile Hemangiomas
NCT04020419Phase 1Terminated
- Start
- Dec 2020
- Primary completion
- May 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised, double-blind trial in infantile hemangioma (IH) comparing Pediaberry group with Placebo (2 arms). Primary endpoint: Decreased Hemangioma Size at 6 months. Started Dec 2020; status: terminated.
02
Drugs
pediaberry
03
Conditions
infantile hemangioma (IH)
Beyond the preview
Go deeper on NCT04020419.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04020419.